Cefpodoxime is a prodrug (cefpodoxime proxetil) converted to the active form after absorption. It exerts bactericidal activity by binding PBPs and inhibiting peptidoglycan cross‑linking. Efficacy correlates with time above the organism’s MIC (time‑dependent killing).